Back to all studies
Active Not RecruitingNCT07164287

Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment

This active not recruiting study focuses on depression and currently lists sites or participation links in Switzerland.

DepressionOtherOver 18 Years
In plain English

Key information made simple

This study exists to see whether the medication Intensity is workable and worth testing more broadly. Researchers are trying to understand whether the medication Intensity can work better when mental health difficulties overlap with substance use. For people living with Depression, being understood earlier and more clearly can shape the whole care journey. If the findings are useful, they could help shape larger studies and better designed support in the future. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including Geneva University Hospital in Geneva. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include safety concerns that need urgent care first and major medical issues that could make participation unsuitable. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT07164287. Your email is the only field you need to provide here.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Switzerland.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com